Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Doffo, Josefina; Bamopoulos, Stefanos A.; Koese, Hazal et al.

NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. Bd. 119. H. 9. 2022


Carlsson, Max J.; Vollmer, Anastasia S.; Demuth, Philipp et al.

p53 triggers mitochondrial apoptosis following DNA damage-dependent replication stress by the hepatotoxin methyleugenol

CELL DEATH & DISEASE. Bd. 13. H. 11. 2022


Liebl, Magdalena C.; Hofmann, Thomas G.

Regulating the p53 Tumor Suppressor Network at PML Biomolecular Condensates

CANCERS. Bd. 14. H. 19. 2022


Beltzig, Lea; Schwarzenbach, Christian; Leukel, Petra et al.

Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells

CANCERS. Bd. 14. H. 9. 2022


Kraemer, Oliver H.; Schneider, Gunter

Single-cell profiling guided combination therapy of c-Fos and histone deacetylase inhibitors in diffuse large B-cell lymphoma

CLINICAL AND TRANSLATIONAL MEDICINE. Bd. 12. H. 5. 2022



Schwarzenbach, Christian; Tatsch, Larissa; Vilar, Juliana Brandstetter et al.

Targeting c-IAP1, c-IAP2, and Bcl-2 eliminates senescent glioblastoma cells following temozolomide treatment

ONCOLOGY RESEARCH AND TREATMENT. Bd. 45. H. SUPPL 3. 2022 S. 49-49


Winkler, Rene; Magdefrau, Ann-Sophie; Piskor, Eva-Maria et al.

Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition

ONCOGENE. Bd. 41. H. 40. 2022 S. 4560-4572


Kaina, Bernd; Beltzig, Lea; Strik, Herwig

Temozolomide - Just a Radiosensitizer?

FRONTIERS IN ONCOLOGY. Bd. 12. 2022